Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-02-10
1986-08-19
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548335, A61K 31415, C07D23360
Patent
active
046070460
ABSTRACT:
4-(1-Imidazolylmethyl)cinnamic acid hydrochloride monohydrate of the formula: ##STR1## and pharmaceutical compositions containing such compound. The imidazole derivative above has a strong and specific inhibitory effect on thromboxane synthetase from human or bovine platelet microsomes, and is useful as a therapeutical agent for inflammation, hypertension, thrombus, cerebral apoplexy, and asthma.
REFERENCES:
patent: 4226878 (1980-10-01), Iizuka et al.
Ogata et al., Kagaku Jikken Sosaho, (1958), pp. 403, 414, 415.
Akahane Kenji
Arikawa Shigeo
Iizuka Kinji
Morita Kaname
Watanabe Mitsuo
Kissei Pharmaceutical Co. Ltd.
Ono Pharmaceutical Co. Ltd.
Ramsuer Robert W.
LandOfFree
4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-394194